Resmed Financial Statements From 2010 to 2024
| RSMDFDelisted Stock | USD 17.70 0.00 0.00% |
Check Resmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Resmed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Resmed financial statements analysis is a perfect complement when working with Resmed Valuation or Volatility modules.
Resmed |
Resmed Inc DRC Company Return On Equity Analysis
Resmed's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Resmed Return On Equity | 0.24 |
Most of Resmed's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Resmed Inc DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Resmed Inc DRC has a Return On Equity of 0.2352. This is 100.98% lower than that of the Healthcare sector and 103.93% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 175.87% lower than that of the firm.
Resmed Inc DRC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Resmed's current stock value. Our valuation model uses many indicators to compare Resmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Resmed competition to find correlations between indicators driving Resmed's intrinsic value. More Info.Resmed Inc DRC is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Resmed Inc DRC is roughly 2.04 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Resmed's earnings, one of the primary drivers of an investment's value.About Resmed Financial Statements
Resmed stakeholders use historical fundamental indicators, such as Resmed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Resmed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Resmed's assets and liabilities are reflected in the revenues and expenses on Resmed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Resmed Inc DRC. Please read more on our technical analysis and fundamental analysis pages.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Resmed Inc operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 8160 people.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Resmed Pink Sheet
If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |